BCI-024
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCI-024, covering 2013-12-17 to 2013-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD) [Phase 2]